Merck and BGI Establish Strategic Collaboration focused on Biomarkers and Genomic Technologies

Merck MRK and BGI announced earlier today that they have established a collaboration to focus on the discovery and development of biomarkers and genomic technologies. Under the agreement scientists from Merck and BGI will work closely together to identify and characterize biomarkers with an emphasis on drug discovery, drug development and diagnostics applications across a wide range of therapeutic areas.